These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9058395)

  • 21. [Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background subtraction method].
    Ueda T; Torihara Y; Tsuneyoshi N; Ikeda Y
    No To Shinkei; 2001 Jul; 53(7):625-30. PubMed ID: 11517486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5HT1B/1D agonists.
    Fox AW
    J Clin Pharmacol; 2002 Nov; 42(11):1281-2; author reply 1282-3. PubMed ID: 12412829
    [No Abstract]   [Full Text] [Related]  

  • 23. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
    Millson DS; Tepper SJ; Rapoport AM
    Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.
    Lofland JH; Nash DB
    Pharmacoeconomics; 2005; 23(3):259-74. PubMed ID: 15836007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migraine: pathophysiology, pharmacology, treatment and future trends.
    Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
    Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Triptans in migraine--here and now (15 years after they were implemented in therapy)].
    Prusiński A; Rozniecki JJ
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model.
    Martelletti P; Stirparo G; Rinaldi C; Fusco BM
    Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin receptors and the acute attack of migraine.
    Goadsby PJ
    Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 31. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecule of the month. Lasmiditan hydrochloride.
    Drug News Perspect; 2010 Sep; 23(7):455. PubMed ID: 20862397
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32.
    Ferrari MD
    Cephalalgia; 2001 Sep; 21(7):711. PubMed ID: 11603382
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
    Goadsby PJ; Hargreaves RJ
    Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ; Charlesworth B
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible role of alpha-adrenoceptor subtypes in acute migraine therapy.
    Willems EW; Valdivia LF; Villalón CM; Saxena PR
    Cephalalgia; 2003 May; 23(4):245-57. PubMed ID: 12716341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
    Amelin AV; Skoromets AA; Ignatov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
    [No Abstract]   [Full Text] [Related]  

  • 39. Migraine and its treatment with 5-HT1B/1D agonists (triptans).
    Moriarty-Sheehan M
    J Am Acad Nurse Pract; 2002 Aug; 14(8):354-9; quiz 360-2. PubMed ID: 12242852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in understanding the pathophysiology of headache.
    Silberstein SD
    Neurology; 1992 Mar; 42(3 Suppl 2):6-10. PubMed ID: 1557193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.